NO20055582D0 - Preparater og fremgangsmater omfattende gastrinforbindelser - Google Patents

Preparater og fremgangsmater omfattende gastrinforbindelser

Info

Publication number
NO20055582D0
NO20055582D0 NO20055582A NO20055582A NO20055582D0 NO 20055582 D0 NO20055582 D0 NO 20055582D0 NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 D0 NO20055582 D0 NO 20055582D0
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
gastrin
compounds
Prior art date
Application number
NO20055582A
Other languages
English (en)
Other versions
NO20055582L (no
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/no
Publication of NO20055582L publication Critical patent/NO20055582L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20055582A 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser NO20055582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 true NO20055582D0 (no) 2005-11-25
NO20055582L NO20055582L (no) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (no) 2003-05-27 2005-11-25 Preparater og fremgangsmater omfattende gastrinforbindelser

Country Status (11)

Country Link
EP (1) EP1648495A2 (no)
JP (1) JP2007513059A (no)
CN (1) CN1829528A (no)
AU (1) AU2004243541A1 (no)
BR (1) BRPI0410710A (no)
CA (1) CA2527186A1 (no)
MX (1) MXPA05012605A (no)
NO (1) NO20055582L (no)
PL (1) PL379145A1 (no)
RU (1) RU2005140518A (no)
WO (1) WO2004105780A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055152A2 (en) 2001-01-12 2002-07-18 Waratah Pharmaceuticals, Inc. Composition for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
EP1511509B1 (en) 2002-06-07 2007-10-10 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
US20090202494A1 (en) * 2004-01-30 2009-08-13 Antonio Cruz Combined use of glp-1 agonists and gastrin for regulating blood glucose levels
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
EP1132091A1 (en) * 1994-01-24 2001-09-12 The General Hospital Corporation Treatment for diabetes
WO2002055152A2 (en) * 2001-01-12 2002-07-18 Waratah Pharmaceuticals, Inc. Composition for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
JP2006506386A (ja) * 2002-10-22 2006-02-23 ワラタ ファーマシューティカルズ， インコーポレイテッド 糖尿病の処置

Also Published As

Publication number Publication date
NO20055582L (no) 2006-02-27
AU2004243541A1 (en) 2004-12-09
WO2004105780A3 (en) 2005-01-20
MXPA05012605A (es) 2006-02-22
BRPI0410710A (pt) 2006-06-13
CA2527186A1 (en) 2004-12-09
CN1829528A (zh) 2006-09-06
WO2004105780A2 (en) 2004-12-09
EP1648495A2 (en) 2006-04-26
PL379145A1 (pl) 2006-07-24
RU2005140518A (ru) 2007-07-10
JP2007513059A (ja) 2007-05-24

Similar Documents

Publication Publication Date Title
NO20055837D0 (no) Immunsupprimerende forbindelser og sammensetninger
IS8320A (is) N-staðgengnir pýrasólýl-amidýl-bensimidasólýl
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
DE602004031845D1 (de) Ng
SE0300741L (sv) Panelfog
DE602004003294D1 (de) Flügelendkantenverstellmechanismus
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DE602004000356T8 (de) Steckverbinder
SE0302091L (sv) Genomföring
IS8273A (is) Nýr búnaður
AT502792A5 (de) Düsenanpressvorrichtung
DE502004002085D1 (de) Mehrfach-bestückkopf
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
IS8489A (is) Umritunarstillar og aðferðir þeirra
NO20030424D0 (no) Brönnhodeplattform
DE602004021612D1 (de) Chtungsmassen
NO20055582D0 (no) Preparater og fremgangsmater omfattende gastrinforbindelser
ATA662003A (de) Trink-mundstück
DE602004018799D1 (de) Ng
ATE514681T1 (de) N-substituierte pyrazolylcarboxanilide
NO20032330D0 (no) Plugg
DE50305802D1 (de) Stanz-prägeniet
DK1680134T3 (da) Sammensætninger og anvendelser deraf
DE602004032031D1 (de) Spielfreie c-ring-anordnung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application